文献速递系统性红斑狼疮

美国系统性红斑狼疮合并脓毒症患者院内死亡率的医院间差异

Interhospital variation in mortality among patients with systemic lupus erythematosus and sepsis in the USA.
PubMed 文献 · Rheumatology (Oxford) · 2019-01-01

基于美国全国住院患者样本(2002-2011)分析424家医院收治的4024例SLE合并脓毒症成人患者,发现院内死亡率在0%至60%之间(中位11.1%),医院间相对SLE死亡风险比(RR)中位0.84,14.4%的医院RR≥2.0;年均收治≥3.9例SLE合并脓毒症的医院RR≥2.0的比例更低(10% vs 17%,P=0.004)。

要点

  • SLE合并脓毒症患者院内死亡率在医院间差异大,范围0%至60%。
  • 14.4%的医院相对SLE死亡风险比≥2.0,提示这些医院SLE患者死亡风险更高。
  • 年均收治SLE合并脓毒症≥3.9例的医院相对死亡风险更低。

核心结论

  • SLE合并脓毒症患者的院内死亡率在医院间差异显著,收治此类患者较多的医院死亡率相对更低。

研究设计与样本

  • 基于美国全国住院患者样本(National Inpatient Sample,2002-2011)的回顾性队列研究,纳入424家医院共4024例SLE合并脓毒症成人患者,并与同院无SLE的脓毒症患者比较。

主要发现

  • 424家医院共收治4024例SLE合并脓毒症患者,院内死亡率范围0%至60%,中位11.1%。
  • 医院水平相对SLE死亡风险比(RR)范围0至9.75,中位0.84,提示平均医院SLE与非SLE患者的观察/预期死亡率相似。
  • 年均收治≥3.9例SLE合并脓毒症的医院RR≥2.0的比例为10%,低于收治较少医院的17%(P=0.004)。

关键数值与推荐

  • 以医院水平相对SLE死亡风险比(RR)≥2.0定义为高相对SLE死亡率。
  • 年均收治SLE合并脓毒症患者≥3.9例为高收治量医院阈值。

临床怎么用

  • 提示SLE合并脓毒症患者的救治结局存在医院间差异,收治量较高的医院相对死亡风险更低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether the risk of mortality in patients with SLE hospitalized with sepsis varies among hospitals in the USA. METHODS: We used the National Inpatient Sample (2002-2011) to obtain national population-based data on outcomes for adults with SLE admitted with sepsis, and compared it with that for patients without SLE admitted with sepsis at the same hospital. We computed expected mortality based on patient demographic characteristics, comorbidities and major organ dysfunction, and calculated observed/expected (O/E) mortality ratios separately for patients with SLE and without SLE for each hospital. We then computed the ratio of these O/E ratios within hospitals to assess relative SLE mortality. We considered hospitals with a risk ratio (RR) of ⩾2.0 as having high relative SLE mortality. RESULTS: Among 424 hospitals that treated a total of 4024 patients with SLE and sepsis, the risk of in-hospital mortality varied from 0% to 60% (median 11.1%). The RR ranged from 0 to 9.75, with a median of 0.84, indicating that O/E mortality was similar in patients with and without SLE at the average hospital. Sixty-one hospitals (14.4%) had a RR of ⩾2.0, indicating higher mortality among patients with SLE. Hospitals that on average treated ⩾3.9 patients with SLE and sepsis annually were less likely to have a RR of ⩾2.0 than hospitals that treated fewer patients (10% vs 17%; P = 0.004). CONCLUSION: Mortality among patients with SLE and sepsis varied widely between hospitals, and was lower at hospitals that treated more of these patients.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Tektonidou MG, Dasgupta A, Ward MM, et al. Interhospital variation in mortality among patients with systemic lupus erythematosus and sepsis in the USA. Rheumatology (Oxford). 2019. PMID: 31323667. doi:10.1093/rheumatology/kez103

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。